Current Assets
Derivative assets
Medtronic Derivative assets increased by 15.0% to $536M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 45.3%, from $980M to $536M. Over 4 years (FY 2021 to FY 2025), Derivative assets shows an upward trend with a 104.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2015
Last reportedQ3 2026Feb 24, 2026
Metric ID:
fin_derivative_assetsHistorical Data
19 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19M | $49M | $154M | $695M | $907M | $1.08B | $341M | $368M | $421M | $720M | $549M | $659M | $668M | $589M | $980M | $334M | $335M | $466M | $536M |
| QoQ Change | — | +157.9% | +214.3% | +351.3% | +30.5% | +19.3% | -68.5% | +7.9% | +14.4% | +71.0% | -23.8% | +20.0% | +1.4% | -11.8% | +66.4% | -65.9% | +0.3% | +39.1% | +15.0% |
| YoY Change | — | — | — | >999% | >999% | +602.6% | — | -47.1% | -53.6% | -33.5% | +61.0% | +79.1% | +58.7% | -18.2% | +78.5% | -49.3% | -49.9% | -20.9% | -45.3% |
Range$19M – $1.08B
CAGR+110.0%
Avg YoY Growth+391.4%
Median YoY Growth-18.2%
Current Streak3 quarters growth
Derivative assets at Other Companies
Frequently Asked Questions
- What is Medtronic's derivative assets?
- Medtronic (MDT) reported derivative assets of $536M in Q4 2025.
- How has Medtronic's derivative assets changed year-over-year?
- Medtronic's derivative assets decreased by 45.3% year-over-year, from $980M to $536M.
- What is the long-term trend for Medtronic's derivative assets?
- Over 4 years (2021 to 2025), Medtronic's derivative assets has grown at a 104.8% compound annual growth rate (CAGR), from $19M to $334M.